Opened 14 Nov 2025 · Days active: 208
$CAMP
Kim Vyacheslav filed a Schedule 13D for Camp4 Therapeutics Corp on 14 November 2025. Schedule 13D indicates active intent.
Read the latest 13D filing on EDGAR →Kim Vyacheslav
Active campaigns
1
Total position
—
Largest position
—
Avg stake size
—
Lifetime campaigns
1
Avg duration
—
Active campaigns
1 campaignPast campaigns
Closed-campaign history pendingIn development
Closed-campaign history ships with campaign tracking.
Once campaign-tracking is online, this section will list every closed 13D / 13G position with its hold duration, peak stake, and outcome. The pipeline requires open-close pairing on amendments — not derivable from individual filings alone.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event Kim is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.
Context
13D vs 13GSchedule 13D and 13G filings are required when an investor crosses 5% beneficial ownership of a public company. A 13D indicates active intent — engagement with management, board representation, strategic proposals. A 13G is the passive equivalent, used by long-term holders who do not intend to influence corporate decisions. Conversion from 13G to 13D, or a 13D amendment, is itself a disclosure event and often signals an inflection point in the activist's posture.
Source data: SEC EDGAR · 13D and 13G filings · Last refreshed 12:17 UTC.